Oscar Lambret Center in France Installs Second Accuray Radixact® System, the Hospital's Fifth Accuray Radiation Therapy Delivery System

Hospital Adds Accuray ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies to Both Radixact Systems, Creating the Ultimate System for Personalized Cancer Care

SUNNYVALE, Calif., Nov. 16, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Oscar Lambret Center in Lille, France has installed its second Radixact ® System and the hospital's fifth Accuray radiation therapy delivery system. The hospital has enhanced both Radixact Systems with the addition of the Accuray-only ClearRT ™ Helical Fan-Beam kVCT Imaging and Synchrony ® technologies, applications designed to improve treatment outcomes and versatility in the types of diseases that can be treated.

ClearRT integrated with Synchrony on the Radixact System provides the tools to increase the precision and accuracy of treatments and as a result, expands the type of external beam radiation therapy that can be delivered with one system. From extremely precise and accurate conventionally fractionated image-guided intensity-modulated radiation therapy (IG-IMRT) to ultra-hypofractionated stereotactic body radiation therapy (SBRT) treatments, the care team has the flexibility to choose the modality that is most appropriate for each patient based on a range of factors including their medical condition and history, age and lifestyle.

"We value our long-standing relationship with the Oscar Lambret team and look forward to partnering with them for many years to come. I believe Accuray technologies support the hospital's patient-focused mission and will enable them to achieve the highest levels of cancer care while increasing the number of people within their community who can be helped on a daily basis," said Suzanne Winter, president and CEO of Accuray.